clinical trials

News

kidney disease computer graphic scan image

Novartis eyes year-end filing in US for Fabhalta in C3G

Novartis is cueing up a new indication in the US for its oral therapy for complement-mediated diseases – Fabhalta – after reporting new data with the drug in ultra-rare kidney disease C3 gl

News

Intellia trumpets CRISPR drug data, but shares fall

Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but i

News

old couple on a park bench taking in the mountain view

UK launches scheme to boost dementia trial participation

A UK initiative to tackle the "historically low" numbers of people taking part in dementia clinical trials has been launched with £20 million ($26 million) in funding from the government.

News

Otsuka eyes early filing of IgAN drug after phase 3 readout

Otsuka is hoping to file for approval of its anti-APRIL antibody sibeprenlimab as a treatment for kidney disorder IgA nephropathy (IgAN) after the drug hit the target in a phase 3 trial.

News

patients in a doctor's surgery at the registration desk

Europe's share of clinical trials falling, with China rising

The proportion of commercially sponsored clinical trials run in Europe almost halved over the last 10 years and is now trailing China, whose share has doubled in the same period.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Enabling site success: Key insights to reducing burden and i...

Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.

Novartis eyes year-end filing in US for Fabhalta in C3G

Intellia trumpets CRISPR drug data, but shares fall

UK launches scheme to boost dementia trial participation

Otsuka eyes early filing of IgAN drug after phase 3 readout

Europe's share of clinical trials falling, with China rising

Enabling site success: Key insights to reducing burden and i...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

clinical trials

Editor's Picks